GlobeNewswire
Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium
📈
AI Sentiment
Highly Positive
8/10
- Home
- PALI
PALI
Palisade Bio Inc.
as of 02-13-2026 3:46pm EST
$1.73
$0.00
-0.29%
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | CARLSBAD |
| Market Cap: | 240.2M | IPO Year: | N/A |
| Target Price: | $15.00 | AVG Volume (30 days): | 4.6M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.53 - $2.64 | Next Earning Date: | 03-23-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -10084000.0 | FCF Growth: | N/A |
AI-Powered PALI Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 78.69%
78.69%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Palisade Bio Inc. (PALI)
Williams Donald Allen
Buy
Director
PALI Jan 16, 2026
Avg Cost/Share
$1.67
Shares
5,000
Total Value
$8,356.00
Owned After
10,728
SEC Form 4
Williams Donald Allen
Buy
Director
PALI Jan 9, 2026
Avg Cost/Share
$1.88
Shares
5,000
Total Value
$9,400.00
Owned After
10,728
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Williams Donald Allen | PALI | Director | Jan 16, 2026 | Buy | $1.67 | 5,000 | $8,356.00 | 10,728 | |
| Williams Donald Allen | PALI | Director | Jan 9, 2026 | Buy | $1.88 | 5,000 | $9,400.00 | 10,728 |
Latest Palisade Bio Inc. News
PALI Breaking Stock News: Dive into PALI Ticker-Specific Updates for Smart Investing
Compare PALI vs Leading Stocks
See how PALI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PALI Palisade Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.